Clinical Trials Directory

Trials / Completed

CompletedNCT04406402

L-arginine and Asymmetric Dimethylarginine (ADMA) and Lifestyle Protocols

The Effects of Different Acute Nutritional Protocols and Lifestyle Modification on Circulating L-arginine and Asymmetric Dimethylarginine (ADMA) in Obese and Type 2 Diabetic Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
243 (actual)
Sponsor
Tel-Aviv Sourasky Medical Center · Other Government
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

Low serum L-arginine (Arg) and high asymmetric dimethylarginine (ADMA) can predict microvascular complications in type 2 diabetes (T2DM). The investigators examined whether or not Arg and ADMA are affected by dietary factors or lifestyle modification in overweight/ obese and T2DM subjects.

Detailed description

The investigators tested the effects on serum Arg and ADMA of a) a single load of ingested dextrose, protein, fat or alcohol, each consumed within 10 minutes; b) a single episode of physical exercise; c) a 12 weeks lifestyle modification program comprised of a standard dietary and physical activity counseling in obese or T2DM subjects on circulating Arg and ADMA (n=43)

Conditions

Interventions

TypeNameDescription
BEHAVIORALAcute dietary protocols and lifestyle modificationThe investigators tested the effects on serum Arg and ADMA of a) a single load of ingested dextrose, protein, fat or alcohol, each consumed within 10 minutes; b) a single episode of physical exercise; c) a 12 weeks lifestyle modification program comprised of a standard dietary and physical activity counseling in obese or T2DM subjects on circulating Arg and ADMA (n=43).

Timeline

Start date
2006-12-05
Primary completion
2008-04-04
Completion
2008-12-10
First posted
2020-05-28
Last updated
2020-06-02

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT04406402. Inclusion in this directory is not an endorsement.